Surgical management of peri-implantitis in adjunction with BlueM oxygen therapy: a case report with 5-years follow-up

Peri-implantitis is an inflammatory disease associated with plaque accumulation in peri-implant tissues, and can cause implant failure. Several surgical and nonsurgical protocols have been proposed to treat patients with peri-implantitis. In this case report, we describe the surgical management of peri-implantitis with the use of BlueM oxygen therapy after mechanical debridement of dental implant surface. Although, several conventional anti-infective modalities have been employed to treat peri-implantitis, the application of topical oxygen therapy can be very effective. The case demonstrated good results with the maintenance of peri-implant bone level and absence of clinical signs of inflammation.

Minimally invasive maxillary sinus augmentation for single dental implant restoration: a case report

This clinical case aims to report a minimally invasive approach for maxillary sinus augmentation for first-molar replacement with a dental implant. A 61-year-old male presented to dental clinic with missing upper right first molar. Panoramic x-ray (OPG) showed insufficient posterior maxillary bone with a residual alveolar bone height<4 mm. The patient underwent a minimally invasive sinus floor elevation and augmentation. Three months postoperatively, and a dental implant (? 4.1×12 mm, bone level, straumann) was placed successfully. Thereafter, at 3-months post-implantation, the final restoration was accomplished. A 12-months follow-up demonstrated satisfactory clinical outcome. In conclusion, the present case-report demonstrates the advantages of the presented technique for sinus augmentation and dental implant restoration with high precision and promising result, in similar cases with a residual alveolar bone height <5 mm.

Risk factors and screening benefits in pregestational and early gestation diabetes

Gestational diabetes is one of the most widespread complications of pregnancy posing a serious clinical and public health challenge. Globally, 16.5% of pregnancies are affected by the gestational diabetes, and this percentage is expected to rise as the obesity pandemic spreads. It has severe short-term and long-term negative health effects on both the mother and the child, which emphasizes the importance of identifying the risk factors for gestational diabetes and taking steps to prevent the illness. Gestational diabetes occurs when pregnant women who have never been diagnosed with diabetes experience chronic hyperglycaemia caused by impaired glucose tolerance. Obesity, physical inactivity, multiparity, family history of diabetes mellitus, certain ethnicities, birth of a previous macrocosmic child are all risk factors for gestational diabetes. Maternal cardiovascular disease, type 2 diabetes, macrosomia, and difficulties in delivery are all some of the complications of gestational diabetes. Additionally, there is a longer-term risk for the child to develop obesity, type 2 diabetes, and cardiovascular disease. Screening and diagnostic tests for gestational diabetes are essential to identify the women who are at risk for developing gestational diabetes and thereafter reduce or eliminate the risk of unfavourable outcomes for both mother and child associated with gestational diabetes. Oral glucose tolerance test is the widely accepted screening test conducted between 24-28 weeks of pregnancy for the diagnosis of gestational diabetes. The purpose of this research is to review the available information about risk factors and screening benefits in pregestational and early gestational diabetes.